Biomedical companies that can harness the power of patient groups will get medicines, devices and diagnostics to market faster, cheaper and smarter, helping patients and rewarding investors. Foundations bring urgency, intelligence and resources like patient data and biospecimens, preclinical models, and trial and recruitment support that can be essential to progressing key steps in the development process. In short, they can influence research.
Please complete this contact form to access the download:
In collaboration with: